Market access and reimbursement in Canada – changes at CADTH
March 12, 2024 | CADTH, Canada, HTA, Market Access, Medtech, Pharma, reimbursement
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? Join Clare Foy (Director – Global Market Access, Mtech Access) as she interviews Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) on Friday 22nd March at 2.00pm (GMT)/10.00am (EDT)/3.00pm (CET) for our next Global Whispers webinar.
In this webinar, we will take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau will explore:
- The market access landscape in Canada
- Upcoming changes at CADTH
- What Canadian payers expect from your value proposition
- Opportunities and challenges when launching new medicines/medical devices/diagnostics in Canada
- How Canada compares to the USA/key European launch markets
- What this means for your global market access strategy
Don Husereau (Adjunct Professor of Medicine, The University of Ottawa)
Don is an Adjunct Professor of Medicine at The University of Ottawa. He is a freelance healthcare researcher, and works with private and public sector life sciences organisations to help them understand the value of health technology and its implications for pricing, reimbursement, and healthcare and innovation policy. In Canada, he has served on National and Provincial Expert appraisal committees and has been an invited expert member of a Federal commission focused on innovation policy. He is also Co-Chair of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Task Force.
We are delighted to welcome Don to the Global Whispers webinar series.
We invite you to put your questions to Don in this session. Please suggest a question when you register or email your questions to info@mtechaccess.co.uk. Register now to join us for the webinar.
If you cannot attend the webinar but would like to know more, please register nonetheless, as all registrants will receive a recording of the webinar.
The webinar is free and is open to all market access, HEOR, strategic and commercial teams in Pharmaceutical, Medtech and Diagnostics companies. We also welcome attendees from healthcare systems. Some colleagues from other organisations may attend at the discretion of Mtech Access.
This content was provided by Petauri Evidence